This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-106b-5p | AKT3 | 2.81 | 0 | -3.33 | 1.0E-5 | miRNATAP | -0.41 | 1.0E-5 | NA | |
2 | hsa-miR-142-3p | AKT3 | 4.35 | 0 | -3.33 | 1.0E-5 | miRanda | -0.16 | 0.00934 | NA | |
3 | hsa-miR-15a-5p | AKT3 | 2.05 | 0 | -3.33 | 1.0E-5 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.37 | 0.00021 | NA | |
4 | hsa-miR-15b-5p | AKT3 | 3.32 | 0 | -3.33 | 1.0E-5 | miRNATAP | -0.25 | 0.00571 | NA | |
5 | hsa-miR-16-5p | AKT3 | 2.94 | 0 | -3.33 | 1.0E-5 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.31 | 0.00086 | NA | |
6 | hsa-miR-29b-3p | AKT3 | 0.67 | 0.23406 | -3.33 | 1.0E-5 | miRNATAP | -0.28 | 0.00031 | 26512921 | MicroRNA 29B mir 29b regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3 |
7 | hsa-miR-3065-5p | AKT3 | 2.14 | 0.06094 | -3.33 | 1.0E-5 | mirMAP | -0.22 | 0 | NA | |
8 | hsa-miR-362-3p | AKT3 | 0.68 | 0.22615 | -3.33 | 1.0E-5 | miRanda | -0.25 | 0.00124 | NA | |
9 | hsa-miR-501-3p | AKT3 | 1.72 | 0.00759 | -3.33 | 1.0E-5 | miRNATAP | -0.18 | 0.00733 | NA | |
10 | hsa-miR-93-5p | AKT3 | 2.66 | 0 | -3.33 | 1.0E-5 | miRNATAP | -0.33 | 0.00021 | NA | |
11 | hsa-miR-342-3p | BCL2L1 | 1.31 | 0.02072 | 0.39 | 0.37256 | PITA; miRanda; miRNATAP | -0.13 | 0.00344 | NA | |
12 | hsa-let-7d-5p | CBL | 0.83 | 0.0127 | -0.22 | 0.60145 | MirTarget | -0.21 | 0.0047 | NA | |
13 | hsa-miR-141-5p | CBL | 7.14 | 0 | -0.22 | 0.60145 | mirMAP | -0.12 | 0.0004 | NA | |
14 | hsa-miR-200c-3p | CBL | 6.47 | 0 | -0.22 | 0.60145 | MirTarget; mirMAP | -0.1 | 0.00481 | NA | |
15 | hsa-miR-29c-3p | CBL | -0.41 | 0.52934 | -0.22 | 0.60145 | mirMAP | -0.12 | 0.00078 | NA | |
16 | hsa-miR-30e-3p | CBL | -0.04 | 0.93258 | -0.22 | 0.60145 | MirTarget | -0.22 | 0.00015 | NA | |
17 | hsa-miR-374a-3p | CBL | 0.47 | 0.30527 | -0.22 | 0.60145 | mirMAP | -0.18 | 0.00096 | NA | |
18 | hsa-miR-3913-5p | CBL | 0.15 | 0.73484 | -0.22 | 0.60145 | MirTarget; miRNATAP | -0.17 | 0.00253 | NA | |
19 | hsa-miR-222-5p | CBLB | 2.52 | 0.00142 | -0.06 | 0.89329 | MirTarget | -0.1 | 0.00159 | NA | |
20 | hsa-let-7a-5p | CCND1 | 0.15 | 0.64531 | 0.15 | 0.87753 | TargetScan; miRNATAP | -0.54 | 0.00245 | NA | |
21 | hsa-miR-106a-5p | CCND1 | 3.99 | 0 | 0.15 | 0.87753 | MirTarget; miRNATAP | -0.43 | 0 | NA | |
22 | hsa-miR-15a-5p | CCND1 | 2.05 | 0 | 0.15 | 0.87753 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.35 | 0.00776 | 22922827 | CCND1 has been found to be a target of miR-15a and miR-16-1 through analysis of complementary sequences between microRNAs and CCND1 mRNA; Moreover the transcription of CCND1 is suppressed by miR-15a and miR-16-1 via direct binding to the CCND1 3'-untranslated region 3'-UTR |
23 | hsa-miR-15b-5p | CCND1 | 3.32 | 0 | 0.15 | 0.87753 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.42 | 0.00029 | NA | |
24 | hsa-miR-20b-5p | CCND1 | 4.57 | 5.0E-5 | 0.15 | 0.87753 | MirTarget; miRNATAP | -0.31 | 0 | NA | |
25 | hsa-miR-34a-5p | CCND1 | 0.83 | 0.04775 | 0.15 | 0.87753 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.42 | 0.00174 | 25792709; 21399894 | This inhibition of proliferation was associated with a decrease in cyclin D1 levels orchestrated principally by HNF-4α a target of miR-34a considered to act as a tumour suppressor in the liver;Quantitative PCR and western analysis confirmed decreased expression of two genes BCL-2 and CCND1 in docetaxel-resistant cells which are both targeted by miR-34a |
26 | hsa-miR-497-5p | CCND1 | -1.44 | 0.02251 | 0.15 | 0.87753 | MirTarget; miRNATAP | -0.25 | 0.00498 | 21350001 | Raf-1 and Ccnd1 were identified as novel direct targets of miR-195 and miR-497 miR-195/497 expression levels in clinical specimens were found to be correlated inversely with malignancy of breast cancer |
27 | hsa-miR-106a-5p | CCND2 | 3.99 | 0 | -2.81 | 0.0014 | miRNATAP | -0.44 | 0 | NA | |
28 | hsa-miR-106b-5p | CCND2 | 2.81 | 0 | -2.81 | 0.0014 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.31 | 0.00374 | NA | |
29 | hsa-miR-10a-3p | CCND2 | 0.97 | 0.31667 | -2.81 | 0.0014 | mirMAP | -0.2 | 0.00011 | NA | |
30 | hsa-miR-130b-5p | CCND2 | 3.74 | 0 | -2.81 | 0.0014 | mirMAP | -0.46 | 0 | NA | |
31 | hsa-miR-141-3p | CCND2 | 7.3 | 0 | -2.81 | 0.0014 | MirTarget; TargetScan | -0.24 | 0.00021 | NA | |
32 | hsa-miR-15b-5p | CCND2 | 3.32 | 0 | -2.81 | 0.0014 | miRNATAP | -0.53 | 0 | NA | |
33 | hsa-miR-16-2-3p | CCND2 | 3.8 | 0 | -2.81 | 0.0014 | mirMAP | -0.29 | 0.00207 | NA | |
34 | hsa-miR-182-5p | CCND2 | 5.87 | 0 | -2.81 | 0.0014 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.28 | 2.0E-5 | NA | |
35 | hsa-miR-183-5p | CCND2 | 6.62 | 0 | -2.81 | 0.0014 | miRNATAP | -0.29 | 0 | NA | |
36 | hsa-miR-191-5p | CCND2 | 1.59 | 0.00074 | -2.81 | 0.0014 | MirTarget | -0.32 | 0.00314 | NA | |
37 | hsa-miR-200a-3p | CCND2 | 6.34 | 0 | -2.81 | 0.0014 | MirTarget | -0.41 | 0 | NA | |
38 | hsa-miR-20b-5p | CCND2 | 4.57 | 5.0E-5 | -2.81 | 0.0014 | miRNATAP | -0.3 | 0 | NA | |
39 | hsa-miR-224-3p | CCND2 | 2.85 | 0.00018 | -2.81 | 0.0014 | mirMAP | -0.22 | 0.00101 | NA | |
40 | hsa-miR-28-5p | CCND2 | -0.82 | 0.02212 | -2.81 | 0.0014 | miRanda | -0.43 | 0.00273 | NA | |
41 | hsa-miR-3065-3p | CCND2 | 1.89 | 0.03082 | -2.81 | 0.0014 | MirTarget; miRNATAP | -0.21 | 0.00027 | NA | |
42 | hsa-miR-3065-5p | CCND2 | 2.14 | 0.06094 | -2.81 | 0.0014 | mirMAP | -0.2 | 0.00026 | NA | |
43 | hsa-miR-30d-3p | CCND2 | -0.07 | 0.85742 | -2.81 | 0.0014 | mirMAP | -0.55 | 1.0E-5 | NA | |
44 | hsa-miR-324-3p | CCND2 | 1.51 | 0.00384 | -2.81 | 0.0014 | miRNAWalker2 validate | -0.44 | 0 | NA | |
45 | hsa-miR-33a-3p | CCND2 | 2.06 | 0.00156 | -2.81 | 0.0014 | MirTarget | -0.27 | 0.00041 | NA | |
46 | hsa-miR-378a-3p | CCND2 | 1.47 | 0.04667 | -2.81 | 0.0014 | miRNAWalker2 validate | -0.19 | 0.00601 | NA | |
47 | hsa-miR-429 | CCND2 | 6.4 | 0 | -2.81 | 0.0014 | miRNATAP | -0.46 | 0 | NA | |
48 | hsa-miR-497-5p | CCND2 | -1.44 | 0.02251 | -2.81 | 0.0014 | MirTarget; miRNATAP | -0.27 | 0.00058 | NA | |
49 | hsa-miR-550a-5p | CCND2 | 1.22 | 0.06138 | -2.81 | 0.0014 | MirTarget | -0.22 | 0.00363 | NA | |
50 | hsa-miR-660-5p | CCND2 | -0.07 | 0.88525 | -2.81 | 0.0014 | mirMAP | -0.29 | 0.00793 | NA | |
51 | hsa-miR-9-3p | CCND2 | 1.69 | 0.12517 | -2.81 | 0.0014 | MirTarget; mirMAP; miRNATAP | -0.14 | 0.00185 | NA | |
52 | hsa-miR-93-5p | CCND2 | 2.66 | 0 | -2.81 | 0.0014 | miRNATAP | -0.48 | 0 | NA | |
53 | hsa-miR-96-5p | CCND2 | 5.63 | 0 | -2.81 | 0.0014 | TargetScan; miRNATAP | -0.24 | 0.0003 | NA | |
54 | hsa-miR-27b-3p | CCND3 | -0.09 | 0.85847 | -0.54 | 0.12437 | miRNAWalker2 validate | -0.14 | 0.00019 | NA | |
55 | hsa-miR-429 | CCND3 | 6.4 | 0 | -0.54 | 0.12437 | miRNATAP | -0.11 | 1.0E-5 | NA | |
56 | hsa-miR-96-5p | CCND3 | 5.63 | 0 | -0.54 | 0.12437 | TargetScan | -0.12 | 1.0E-5 | NA | |
57 | hsa-miR-24-3p | CISH | 1.56 | 0.00052 | -0.89 | 0.10733 | MirTarget | -0.25 | 0.00041 | NA | |
58 | hsa-miR-324-5p | CISH | 1.31 | 0.01168 | -0.89 | 0.10733 | miRanda | -0.2 | 0.0012 | NA | |
59 | hsa-miR-200b-3p | CNTFR | 5.56 | 0 | -4.16 | 0.0243 | TargetScan | -0.44 | 0.00218 | NA | |
60 | hsa-miR-200c-3p | CNTFR | 6.47 | 0 | -4.16 | 0.0243 | miRNATAP | -0.62 | 9.0E-5 | NA | |
61 | hsa-miR-21-5p | CNTFR | 2.65 | 0 | -4.16 | 0.0243 | miRNATAP | -0.95 | 0.00229 | NA | |
62 | hsa-miR-429 | CNTFR | 6.4 | 0 | -4.16 | 0.0243 | PITA; miRanda; miRNATAP | -0.37 | 0.00625 | NA | |
63 | hsa-miR-589-5p | CNTFR | 1.56 | 0.00033 | -4.16 | 0.0243 | miRNATAP | -0.63 | 0.00999 | NA | |
64 | hsa-miR-21-3p | CREBBP | 3.5 | 0 | -0.4 | 0.18067 | MirTarget | -0.14 | 0 | NA | |
65 | hsa-miR-590-3p | CREBBP | 2.35 | 0 | -0.4 | 0.18067 | PITA; miRanda; mirMAP; miRNATAP | -0.1 | 0.00219 | NA | |
66 | hsa-miR-217 | CSF2RA | -0.38 | 0.71741 | 1.05 | 0.28308 | miRanda | -0.23 | 1.0E-5 | NA | |
67 | hsa-miR-429 | CSF2RA | 6.4 | 0 | 1.05 | 0.28308 | miRanda | -0.22 | 0.00182 | NA | |
68 | hsa-miR-15b-3p | CSF2RB | 3.58 | 0 | -0.53 | 0.5247 | mirMAP | -0.24 | 0.00379 | NA | |
69 | hsa-miR-19b-3p | CSF2RB | 1.68 | 0.00086 | -0.53 | 0.5247 | MirTarget | -0.25 | 0.00793 | NA | |
70 | hsa-miR-30b-3p | CSF2RB | 0.17 | 0.76608 | -0.53 | 0.5247 | MirTarget | -0.28 | 0.00087 | NA | |
71 | hsa-miR-30b-3p | CSF3R | 0.17 | 0.76608 | 0.32 | 0.72354 | MirTarget | -0.25 | 0.00528 | NA | |
72 | hsa-miR-361-5p | CSF3R | 0.01 | 0.9852 | 0.32 | 0.72354 | miRanda | -0.61 | 3.0E-5 | NA | |
73 | hsa-miR-429 | CSF3R | 6.4 | 0 | 0.32 | 0.72354 | miRanda | -0.2 | 0.00181 | NA | |
74 | hsa-miR-185-5p | CTF1 | 2.47 | 0 | -2.6 | 0.00053 | MirTarget | -0.41 | 1.0E-5 | NA | |
75 | hsa-miR-342-3p | CTF1 | 1.31 | 0.02072 | -2.6 | 0.00053 | miRanda | -0.23 | 0.00232 | NA | |
76 | hsa-miR-148a-3p | EP300 | 1.1 | 0.05204 | 0.22 | 0.57893 | miRNATAP | -0.1 | 0.00975 | NA | |
77 | hsa-miR-30c-5p | EP300 | 0.39 | 0.34861 | 0.22 | 0.57893 | miRNAWalker2 validate | -0.19 | 0.0009 | NA | |
78 | hsa-miR-339-5p | EP300 | 1.23 | 0.03075 | 0.22 | 0.57893 | miRanda | -0.2 | 0 | NA | |
79 | hsa-miR-342-3p | EP300 | 1.31 | 0.02072 | 0.22 | 0.57893 | MirTarget; PITA; miRanda; miRNATAP | -0.12 | 0.00407 | NA | |
80 | hsa-miR-374b-5p | EP300 | -0.11 | 0.76489 | 0.22 | 0.57893 | mirMAP; miRNATAP | -0.16 | 0.00856 | NA | |
81 | hsa-miR-590-3p | EP300 | 2.35 | 0 | 0.22 | 0.57893 | MirTarget; PITA; miRanda; mirMAP; miRNATAP | -0.14 | 0.00229 | NA | |
82 | hsa-miR-15a-5p | GHR | 2.05 | 0 | -3.3 | 0.01335 | MirTarget; miRNATAP | -0.68 | 9.0E-5 | NA | |
83 | hsa-miR-15b-5p | GHR | 3.32 | 0 | -3.3 | 0.01335 | MirTarget; miRNATAP | -0.52 | 0.00106 | NA | |
84 | hsa-miR-16-2-3p | GHR | 3.8 | 0 | -3.3 | 0.01335 | mirMAP | -0.5 | 0.00041 | NA | |
85 | hsa-miR-16-5p | GHR | 2.94 | 0 | -3.3 | 0.01335 | MirTarget; miRNATAP | -0.56 | 0.00046 | NA | |
86 | hsa-miR-3065-5p | GHR | 2.14 | 0.06094 | -3.3 | 0.01335 | MirTarget | -0.38 | 0 | NA | |
87 | hsa-miR-338-5p | GHR | -0.11 | 0.89468 | -3.3 | 0.01335 | PITA | -0.5 | 0 | NA | |
88 | hsa-miR-7-1-3p | GHR | 1.43 | 0.00471 | -3.3 | 0.01335 | MirTarget; mirMAP | -0.41 | 0.00648 | NA | |
89 | hsa-miR-1271-5p | IFNAR2 | 0.21 | 0.74254 | -0.05 | 0.87658 | mirMAP | -0.13 | 2.0E-5 | NA | |
90 | hsa-miR-508-3p | IFNE | 0.98 | 0.43953 | 4.56 | 0.00032 | MirTarget | -0.17 | 0.00391 | NA | |
91 | hsa-miR-125a-5p | IFNG | -1.32 | 0.00714 | 3.94 | 0.0051 | miRanda | -0.64 | 9.0E-5 | NA | |
92 | hsa-miR-369-3p | IFNG | 0.37 | 0.63876 | 3.94 | 0.0051 | PITA; miRNATAP | -0.31 | 0.00283 | NA | |
93 | hsa-miR-409-3p | IFNG | 0.29 | 0.67815 | 3.94 | 0.0051 | miRNAWalker2 validate | -0.43 | 0.00012 | NA | |
94 | hsa-miR-429 | IFNG | 6.4 | 0 | 3.94 | 0.0051 | miRanda | -0.3 | 0.00378 | NA | |
95 | hsa-miR-362-3p | IFNGR1 | 0.68 | 0.22615 | 0.12 | 0.78871 | miRanda | -0.12 | 0.00701 | NA | |
96 | hsa-miR-429 | IFNGR1 | 6.4 | 0 | 0.12 | 0.78871 | miRNATAP | -0.13 | 3.0E-5 | NA | |
97 | hsa-miR-375 | IFNK | 3.38 | 0.04499 | 1.68 | 0.22278 | miRanda | -0.18 | 0.0001 | NA | |
98 | hsa-miR-106a-5p | IL10 | 3.99 | 0 | 2.55 | 0.00205 | miRNAWalker2 validate | -0.17 | 0.00228 | NA | |
99 | hsa-miR-361-5p | IL10 | 0.01 | 0.9852 | 2.55 | 0.00205 | MirTarget; PITA; miRanda; miRNATAP | -0.37 | 0.0076 | NA | |
100 | hsa-miR-3607-3p | IL11 | 1.38 | 0.02401 | 2.82 | 0.01391 | MirTarget | -0.37 | 0.00053 | NA | |
101 | hsa-miR-330-5p | IL11RA | 2.25 | 0.00028 | -2.49 | 1.0E-5 | miRanda | -0.23 | 1.0E-5 | NA | |
102 | hsa-miR-217 | IL12RB1 | -0.38 | 0.71741 | 1.63 | 0.096 | miRanda | -0.15 | 0.00464 | NA | |
103 | hsa-miR-125a-5p | IL12RB2 | -1.32 | 0.00714 | 4.35 | 0.00344 | miRanda | -1.12 | 0 | NA | |
104 | hsa-miR-129-5p | IL12RB2 | -2.67 | 0.00696 | 4.35 | 0.00344 | miRanda | -0.32 | 0.00017 | NA | |
105 | hsa-miR-28-5p | IL12RB2 | -0.82 | 0.02212 | 4.35 | 0.00344 | miRanda | -0.87 | 0.0003 | NA | |
106 | hsa-miR-338-3p | IL12RB2 | 0.45 | 0.55849 | 4.35 | 0.00344 | miRanda | -0.61 | 0 | NA | |
107 | hsa-miR-16-2-3p | IL13RA1 | 3.8 | 0 | 0.06 | 0.87403 | MirTarget | -0.11 | 0.00849 | NA | |
108 | hsa-miR-378a-5p | IL13RA1 | 1.26 | 0.05009 | 0.06 | 0.87403 | MirTarget | -0.12 | 0.00077 | NA | |
109 | hsa-miR-129-5p | IL15 | -2.67 | 0.00696 | 0.47 | 0.59811 | miRanda | -0.28 | 0 | NA | |
110 | hsa-miR-130b-3p | IL15 | 3.92 | 0 | 0.47 | 0.59811 | MirTarget | -0.47 | 0 | NA | |
111 | hsa-miR-301a-3p | IL15 | 1.99 | 0.00081 | 0.47 | 0.59811 | MirTarget | -0.26 | 0.00197 | NA | |
112 | hsa-miR-324-5p | IL15 | 1.31 | 0.01168 | 0.47 | 0.59811 | miRanda | -0.33 | 0.00067 | NA | |
113 | hsa-miR-421 | IL15 | 1.98 | 0.00092 | 0.47 | 0.59811 | miRanda | -0.28 | 0.0009 | NA | |
114 | hsa-miR-429 | IL15 | 6.4 | 0 | 0.47 | 0.59811 | miRanda | -0.25 | 8.0E-5 | NA | |
115 | hsa-miR-493-5p | IL15 | 0.17 | 0.8342 | 0.47 | 0.59811 | MirTarget | -0.21 | 0.00066 | NA | |
116 | hsa-miR-125a-5p | IL15RA | -1.32 | 0.00714 | -0.81 | 0.2072 | miRanda | -0.2 | 0.00633 | NA | |
117 | hsa-miR-199a-5p | IL15RA | -1.25 | 0.07478 | -0.81 | 0.2072 | miRanda | -0.21 | 6.0E-5 | NA | |
118 | hsa-miR-28-5p | IL15RA | -0.82 | 0.02212 | -0.81 | 0.2072 | miRanda | -0.28 | 0.00692 | NA | |
119 | hsa-miR-335-3p | IL19 | 1.2 | 0.09389 | 0.99 | 0.52932 | MirTarget | -0.37 | 0.00336 | NA | |
120 | hsa-miR-125a-3p | IL20RB | -0.07 | 0.92074 | 5.71 | 0.00123 | miRanda | -0.44 | 0.00104 | NA | |
121 | hsa-miR-28-5p | IL20RB | -0.82 | 0.02212 | 5.71 | 0.00123 | miRanda | -1.39 | 0 | NA | |
122 | hsa-miR-199a-5p | IL21R | -1.25 | 0.07478 | 2.85 | 0.00444 | miRanda | -0.26 | 0.00148 | NA | |
123 | hsa-miR-335-5p | IL21R | 0.17 | 0.8039 | 2.85 | 0.00444 | miRNAWalker2 validate | -0.27 | 0.00159 | NA | |
124 | hsa-miR-125a-5p | IL22RA1 | -1.32 | 0.00714 | 3.48 | 7.0E-5 | miRanda | -0.37 | 0.00027 | NA | |
125 | hsa-miR-129-5p | IL22RA2 | -2.67 | 0.00696 | 3.13 | 0.02231 | miRanda | -0.3 | 0.00017 | NA | |
126 | hsa-miR-361-5p | IL24 | 0.01 | 0.9852 | 2.5 | 0.11156 | miRanda | -0.76 | 0.00361 | NA | |
127 | hsa-miR-429 | IL24 | 6.4 | 0 | 2.5 | 0.11156 | miRanda | -0.31 | 0.00666 | NA | |
128 | hsa-miR-199a-5p | IL2RA | -1.25 | 0.07478 | 2.6 | 0.00695 | miRanda | -0.28 | 0.00032 | NA | |
129 | hsa-miR-3065-3p | IL2RA | 1.89 | 0.03082 | 2.6 | 0.00695 | MirTarget | -0.21 | 0.00066 | NA | |
130 | hsa-miR-375 | IL2RA | 3.38 | 0.04499 | 2.6 | 0.00695 | miRanda | -0.18 | 0 | NA | |
131 | hsa-miR-500a-3p | IL2RA | 0.52 | 0.33508 | 2.6 | 0.00695 | MirTarget | -0.31 | 0.0027 | NA | |
132 | hsa-miR-145-5p | IL2RB | -3.56 | 0 | 1.38 | 0.10349 | mirMAP | -0.22 | 0.00084 | NA | |
133 | hsa-miR-299-5p | IL2RB | -1.26 | 0.10353 | 1.38 | 0.10349 | mirMAP | -0.18 | 0.00368 | NA | |
134 | hsa-miR-331-3p | IL4R | 2.61 | 0 | 0.37 | 0.54345 | miRNAWalker2 validate | -0.18 | 0.00755 | NA | |
135 | hsa-miR-429 | IL4R | 6.4 | 0 | 0.37 | 0.54345 | miRNATAP | -0.21 | 0 | NA | |
136 | hsa-miR-491-5p | IL4R | 0.57 | 0.31331 | 0.37 | 0.54345 | miRanda | -0.19 | 0.00182 | NA | |
137 | hsa-miR-429 | IL6 | 6.4 | 0 | -0.81 | 0.55699 | miRanda | -0.5 | 0 | NA | |
138 | hsa-miR-130a-5p | IL6R | 1.58 | 0.02435 | -1.32 | 0.11928 | MirTarget; miRNATAP | -0.2 | 0.00453 | NA | |
139 | hsa-miR-141-3p | IL6R | 7.3 | 0 | -1.32 | 0.11928 | MirTarget | -0.18 | 0.00323 | NA | |
140 | hsa-miR-182-5p | IL6R | 5.87 | 0 | -1.32 | 0.11928 | mirMAP | -0.18 | 0.00348 | NA | |
141 | hsa-miR-200a-3p | IL6R | 6.34 | 0 | -1.32 | 0.11928 | MirTarget | -0.19 | 0.00116 | NA | |
142 | hsa-let-7a-3p | IL6ST | 0.83 | 0.04681 | -0.27 | 0.81784 | mirMAP | -0.52 | 0.00103 | NA | |
143 | hsa-miR-1301-3p | IL6ST | 2.03 | 0.00096 | -0.27 | 0.81784 | MirTarget | -0.37 | 0.00053 | NA | |
144 | hsa-miR-148b-5p | IL6ST | 2.81 | 0 | -0.27 | 0.81784 | mirMAP | -0.4 | 0.0015 | NA | |
145 | hsa-miR-182-5p | IL6ST | 5.87 | 0 | -0.27 | 0.81784 | mirMAP | -0.31 | 0.00021 | NA | |
146 | hsa-miR-24-1-5p | IL6ST | -0.64 | 0.23613 | -0.27 | 0.81784 | MirTarget | -0.36 | 0.00278 | NA | |
147 | hsa-miR-26b-5p | IL6ST | 0.31 | 0.46163 | -0.27 | 0.81784 | mirMAP | -0.41 | 0.00882 | NA | |
148 | hsa-miR-28-3p | IL6ST | -0.99 | 0.01882 | -0.27 | 0.81784 | mirMAP | -0.48 | 0.00217 | NA | |
149 | hsa-miR-29b-2-5p | IL6ST | -0.6 | 0.18954 | -0.27 | 0.81784 | mirMAP | -0.43 | 0.00338 | NA | |
150 | hsa-miR-30b-5p | IL6ST | 0.02 | 0.95322 | -0.27 | 0.81784 | mirMAP | -0.48 | 0.00352 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CYTOKINE MEDIATED SIGNALING PATHWAY | 46 | 452 | 4.616e-53 | 2.148e-49 |
2 | RESPONSE TO CYTOKINE | 50 | 714 | 5.114e-50 | 1.19e-46 |
3 | CELLULAR RESPONSE TO CYTOKINE STIMULUS | 47 | 606 | 1.113e-48 | 1.727e-45 |
4 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 63 | 1848 | 1.473e-46 | 1.714e-43 |
5 | REGULATION OF JAK STAT CASCADE | 24 | 144 | 4.345e-32 | 3.369e-29 |
6 | REGULATION OF STAT CASCADE | 24 | 144 | 4.345e-32 | 3.369e-29 |
7 | STAT CASCADE | 16 | 50 | 1.366e-26 | 7.946e-24 |
8 | JAK STAT CASCADE | 16 | 50 | 1.366e-26 | 7.946e-24 |
9 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 45 | 1656 | 2.443e-26 | 1.263e-23 |
10 | POSITIVE REGULATION OF STAT CASCADE | 16 | 73 | 1.356e-23 | 5.734e-21 |
11 | POSITIVE REGULATION OF JAK STAT CASCADE | 16 | 73 | 1.356e-23 | 5.734e-21 |
12 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 41 | 1618 | 1.719e-22 | 6.664e-20 |
13 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 43 | 1929 | 1.421e-21 | 5.085e-19 |
14 | REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN | 13 | 44 | 3.103e-21 | 1.031e-18 |
15 | REGULATION OF PROTEIN MODIFICATION PROCESS | 40 | 1710 | 1.34e-20 | 4.158e-18 |
16 | REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 14 | 68 | 2.492e-20 | 7.247e-18 |
17 | POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN | 12 | 37 | 3.051e-20 | 8.35e-18 |
18 | IMMUNE SYSTEM PROCESS | 42 | 1984 | 3.86e-20 | 9.979e-18 |
19 | INTRACELLULAR SIGNAL TRANSDUCTION | 38 | 1572 | 6.242e-20 | 1.529e-17 |
20 | REGULATION OF IMMUNE RESPONSE | 30 | 858 | 7.467e-20 | 1.737e-17 |
21 | CELL ACTIVATION | 25 | 568 | 7.817e-19 | 1.732e-16 |
22 | LYMPHOCYTE ACTIVATION | 21 | 342 | 8.881e-19 | 1.878e-16 |
23 | REGULATION OF IMMUNE SYSTEM PROCESS | 35 | 1403 | 1.233e-18 | 2.495e-16 |
24 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 29 | 876 | 1.592e-18 | 3.086e-16 |
25 | REGULATION OF KINASE ACTIVITY | 27 | 776 | 9.311e-18 | 1.733e-15 |
26 | REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 17 | 213 | 3.192e-17 | 5.712e-15 |
27 | LEUKOCYTE ACTIVATION | 21 | 414 | 4.369e-17 | 7.529e-15 |
28 | REGULATION OF CELL PROLIFERATION | 34 | 1496 | 7.992e-17 | 1.328e-14 |
29 | LYMPHOCYTE DIFFERENTIATION | 16 | 209 | 5.758e-16 | 9.238e-14 |
30 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 33 | 1492 | 6.019e-16 | 9.336e-14 |
31 | REGULATION OF DEFENSE RESPONSE | 25 | 759 | 7.059e-16 | 1.059e-13 |
32 | REGULATION OF HOMOTYPIC CELL CELL ADHESION | 18 | 307 | 8.101e-16 | 1.178e-13 |
33 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 28 | 1036 | 1.321e-15 | 1.756e-13 |
34 | REGULATION OF TRANSFERASE ACTIVITY | 27 | 946 | 1.286e-15 | 1.756e-13 |
35 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 28 | 1036 | 1.321e-15 | 1.756e-13 |
36 | PHOSPHORYLATION | 30 | 1228 | 1.427e-15 | 1.845e-13 |
37 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 29 | 1135 | 1.534e-15 | 1.929e-13 |
38 | REGULATION OF CELL CELL ADHESION | 19 | 380 | 2.162e-15 | 2.647e-13 |
39 | POSITIVE REGULATION OF CELL PROLIFERATION | 25 | 814 | 3.528e-15 | 4.209e-13 |
40 | POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 14 | 162 | 8.122e-15 | 9.448e-13 |
41 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 23 | 689 | 9.685e-15 | 1.099e-12 |
42 | CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS | 8 | 20 | 1.011e-14 | 1.12e-12 |
43 | PROTEIN PHOSPHORYLATION | 26 | 944 | 1.144e-14 | 1.238e-12 |
44 | REGULATION OF CELL ACTIVATION | 20 | 484 | 1.346e-14 | 1.423e-12 |
45 | REGULATION OF CELL ADHESION | 22 | 629 | 1.592e-14 | 1.646e-12 |
46 | NEGATIVE REGULATION OF CELL DEATH | 25 | 872 | 1.694e-14 | 1.713e-12 |
47 | POSITIVE REGULATION OF CELL ACTIVATION | 17 | 311 | 1.777e-14 | 1.759e-12 |
48 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 30 | 1360 | 2.161e-14 | 2.095e-12 |
49 | RESPONSE TO HORMONE | 25 | 893 | 2.904e-14 | 2.757e-12 |
50 | POSITIVE REGULATION OF CELL COMMUNICATION | 31 | 1532 | 7.079e-14 | 6.588e-12 |
51 | LEUKOCYTE DIFFERENTIATION | 16 | 292 | 1.092e-13 | 9.959e-12 |
52 | RESPONSE TO NITROGEN COMPOUND | 24 | 859 | 1.117e-13 | 9.994e-12 |
53 | RESPONSE TO ENDOGENOUS STIMULUS | 30 | 1450 | 1.161e-13 | 1.02e-11 |
54 | POSITIVE REGULATION OF CELL CELL ADHESION | 15 | 243 | 1.219e-13 | 1.05e-11 |
55 | REGULATION OF RESPONSE TO STRESS | 30 | 1468 | 1.602e-13 | 1.355e-11 |
56 | REGULATION OF CELL DEATH | 30 | 1472 | 1.72e-13 | 1.429e-11 |
57 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 23 | 799 | 2.182e-13 | 1.782e-11 |
58 | LEUKOCYTE CELL CELL ADHESION | 15 | 255 | 2.464e-13 | 1.977e-11 |
59 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 19 | 498 | 2.804e-13 | 2.211e-11 |
60 | POSITIVE REGULATION OF CYTOKINE PRODUCTION | 17 | 370 | 3.011e-13 | 2.335e-11 |
61 | REGULATION OF HEMOPOIESIS | 16 | 314 | 3.341e-13 | 2.548e-11 |
62 | NEGATIVE REGULATION OF CELL COMMUNICATION | 27 | 1192 | 3.419e-13 | 2.566e-11 |
63 | IMMUNE RESPONSE | 26 | 1100 | 3.996e-13 | 2.951e-11 |
64 | RESPONSE TO GROWTH HORMONE | 8 | 30 | 4.538e-13 | 3.299e-11 |
65 | REGULATION OF T CELL DIFFERENTIATION | 11 | 107 | 1.064e-12 | 7.616e-11 |
66 | REGULATION OF LEUKOCYTE DIFFERENTIATION | 14 | 232 | 1.168e-12 | 8.221e-11 |
67 | POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 23 | 867 | 1.184e-12 | 8.221e-11 |
68 | RESPONSE TO PEPTIDE | 17 | 404 | 1.238e-12 | 8.348e-11 |
69 | PEPTIDYL TYROSINE MODIFICATION | 13 | 186 | 1.229e-12 | 8.348e-11 |
70 | POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 10 | 80 | 1.625e-12 | 1.08e-10 |
71 | CELLULAR RESPONSE TO HORMONE STIMULUS | 19 | 552 | 1.721e-12 | 1.128e-10 |
72 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 28 | 1395 | 2.08e-12 | 1.344e-10 |
73 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 24 | 1008 | 3.43e-12 | 2.186e-10 |
74 | POSITIVE REGULATION OF HEMOPOIESIS | 12 | 163 | 5.184e-12 | 3.139e-10 |
75 | DEFENSE RESPONSE | 26 | 1231 | 5.159e-12 | 3.139e-10 |
76 | LEUKOCYTE MIGRATION | 14 | 259 | 5.195e-12 | 3.139e-10 |
77 | POSITIVE REGULATION OF CELL ADHESION | 16 | 376 | 5.179e-12 | 3.139e-10 |
78 | CELL PROLIFERATION | 20 | 672 | 5.823e-12 | 3.474e-10 |
79 | POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION | 11 | 131 | 1.003e-11 | 5.906e-10 |
80 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 27 | 1381 | 1.07e-11 | 6.226e-10 |
81 | REGULATION OF LYMPHOCYTE DIFFERENTIATION | 11 | 132 | 1.09e-11 | 6.262e-10 |
82 | REGULATION OF CYTOKINE PRODUCTION | 18 | 563 | 2.431e-11 | 1.38e-09 |
83 | JAK STAT CASCADE INVOLVED IN GROWTH HORMONE SIGNALING PATHWAY | 6 | 15 | 2.569e-11 | 1.44e-09 |
84 | REGULATION OF INFLAMMATORY RESPONSE | 14 | 294 | 2.841e-11 | 1.574e-09 |
85 | REGULATION OF T CELL PROLIFERATION | 11 | 147 | 3.537e-11 | 1.936e-09 |
86 | IMMUNE SYSTEM DEVELOPMENT | 18 | 582 | 4.188e-11 | 2.266e-09 |
87 | NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 16 | 437 | 4.9e-11 | 2.62e-09 |
88 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 31 | 1977 | 5.664e-11 | 2.995e-09 |
89 | REGULATION OF CELL DIFFERENTIATION | 27 | 1492 | 6.278e-11 | 3.282e-09 |
90 | REGULATION OF LEUKOCYTE PROLIFERATION | 12 | 206 | 8.109e-11 | 4.192e-09 |
91 | SINGLE ORGANISM CELL ADHESION | 16 | 459 | 1.012e-10 | 5.176e-09 |
92 | T CELL DIFFERENTIATION | 10 | 123 | 1.275e-10 | 6.45e-09 |
93 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 21 | 917 | 2.085e-10 | 1.043e-08 |
94 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 23 | 1142 | 3.014e-10 | 1.492e-08 |
95 | NEGATIVE REGULATION OF PHOSPHORYLATION | 15 | 422 | 3.174e-10 | 1.555e-08 |
96 | REGULATION OF INNATE IMMUNE RESPONSE | 14 | 357 | 3.675e-10 | 1.781e-08 |
97 | REGULATION OF RESPONSE TO INTERFERON GAMMA | 6 | 22 | 3.738e-10 | 1.793e-08 |
98 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 16 | 505 | 4.097e-10 | 1.945e-08 |
99 | REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 10 | 144 | 6.066e-10 | 2.851e-08 |
100 | CELL CELL ADHESION | 17 | 608 | 7.348e-10 | 3.385e-08 |
101 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 28 | 1791 | 7.314e-10 | 3.385e-08 |
102 | RESPONSE TO EXTERNAL STIMULUS | 28 | 1821 | 1.067e-09 | 4.865e-08 |
103 | REGULATION OF GROWTH | 17 | 633 | 1.353e-09 | 6.112e-08 |
104 | PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 7 | 49 | 1.573e-09 | 7.038e-08 |
105 | POSITIVE REGULATION OF IMMUNE RESPONSE | 16 | 563 | 1.968e-09 | 8.722e-08 |
106 | CELLULAR RESPONSE TO PEPTIDE | 12 | 274 | 2.136e-09 | 9.376e-08 |
107 | IMMUNE EFFECTOR PROCESS | 15 | 486 | 2.198e-09 | 9.557e-08 |
108 | PEPTIDYL AMINO ACID MODIFICATION | 19 | 841 | 2.218e-09 | 9.557e-08 |
109 | REGULATION OF RESPONSE TO WOUNDING | 14 | 413 | 2.42e-09 | 1.033e-07 |
110 | REGULATION OF MAPK CASCADE | 17 | 660 | 2.537e-09 | 1.073e-07 |
111 | REGULATION OF ADAPTIVE IMMUNE RESPONSE | 9 | 123 | 2.891e-09 | 1.212e-07 |
112 | REGULATION OF IMMUNE EFFECTOR PROCESS | 14 | 424 | 3.387e-09 | 1.407e-07 |
113 | NATURAL KILLER CELL ACTIVATION | 7 | 55 | 3.64e-09 | 1.499e-07 |
114 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 26 | 1672 | 4.067e-09 | 1.634e-07 |
115 | HOMEOSTASIS OF NUMBER OF CELLS | 10 | 175 | 4.055e-09 | 1.634e-07 |
116 | POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 8 | 88 | 4.074e-09 | 1.634e-07 |
117 | RESPONSE TO ALCOHOL | 13 | 362 | 4.776e-09 | 1.899e-07 |
118 | RESPONSE TO BIOTIC STIMULUS | 19 | 886 | 5.203e-09 | 2.052e-07 |
119 | REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 7 | 59 | 6.035e-09 | 2.36e-07 |
120 | POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION | 9 | 136 | 7.029e-09 | 2.726e-07 |
121 | POSITIVE REGULATION OF T CELL PROLIFERATION | 8 | 95 | 7.519e-09 | 2.891e-07 |
122 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 15 | 541 | 9.313e-09 | 3.523e-07 |
123 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 15 | 541 | 9.313e-09 | 3.523e-07 |
124 | REGULATION OF CELL KILLING | 7 | 63 | 9.653e-09 | 3.622e-07 |
125 | NEGATIVE REGULATION OF KINASE ACTIVITY | 11 | 250 | 1.001e-08 | 3.725e-07 |
126 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 14 | 470 | 1.251e-08 | 4.619e-07 |
127 | CELL MOTILITY | 18 | 835 | 1.303e-08 | 4.735e-07 |
128 | LOCALIZATION OF CELL | 18 | 835 | 1.303e-08 | 4.735e-07 |
129 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 24 | 1518 | 1.399e-08 | 5.046e-07 |
130 | POSITIVE REGULATION OF KINASE ACTIVITY | 14 | 482 | 1.717e-08 | 6.147e-07 |
131 | REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 9 | 156 | 2.335e-08 | 8.294e-07 |
132 | REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 8 | 114 | 3.187e-08 | 1.123e-06 |
133 | NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY | 6 | 44 | 3.279e-08 | 1.13e-06 |
134 | NEGATIVE REGULATION OF JAK STAT CASCADE | 6 | 44 | 3.279e-08 | 1.13e-06 |
135 | NEGATIVE REGULATION OF STAT CASCADE | 6 | 44 | 3.279e-08 | 1.13e-06 |
136 | RESPONSE TO ESTROGEN | 10 | 218 | 3.312e-08 | 1.133e-06 |
137 | RESPONSE TO LIPID | 18 | 888 | 3.342e-08 | 1.135e-06 |
138 | REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 8 | 118 | 4.178e-08 | 1.409e-06 |
139 | PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 8 | 120 | 4.765e-08 | 1.595e-06 |
140 | NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 15 | 616 | 5.183e-08 | 1.723e-06 |
141 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 17 | 823 | 6.525e-08 | 2.135e-06 |
142 | PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 5 | 25 | 6.488e-08 | 2.135e-06 |
143 | TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 4 | 10 | 6.561e-08 | 2.135e-06 |
144 | REGULATION OF ERBB SIGNALING PATHWAY | 7 | 83 | 6.759e-08 | 2.184e-06 |
145 | INFLAMMATORY RESPONSE | 13 | 454 | 6.914e-08 | 2.219e-06 |
146 | NEGATIVE REGULATION OF CELL PROLIFERATION | 15 | 643 | 9.064e-08 | 2.889e-06 |
147 | POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 5 | 27 | 9.793e-08 | 3.1e-06 |
148 | B CELL ACTIVATION | 8 | 132 | 1.002e-07 | 3.149e-06 |
149 | LEUKOCYTE PROLIFERATION | 7 | 88 | 1.016e-07 | 3.172e-06 |
150 | RESPONSE TO VIRUS | 10 | 247 | 1.07e-07 | 3.321e-06 |
151 | EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 55 | 1.297e-07 | 3.996e-06 |
152 | REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 8 | 138 | 1.413e-07 | 4.327e-06 |
153 | HOMEOSTATIC PROCESS | 21 | 1337 | 1.571e-07 | 4.778e-06 |
154 | RESPONSE TO STEROID HORMONE | 13 | 497 | 1.963e-07 | 5.932e-06 |
155 | RESPONSE TO ESTRADIOL | 8 | 146 | 2.183e-07 | 6.552e-06 |
156 | MYELOID LEUKOCYTE MIGRATION | 7 | 99 | 2.293e-07 | 6.796e-06 |
157 | LIPID PHOSPHORYLATION | 7 | 99 | 2.293e-07 | 6.796e-06 |
158 | RESPONSE TO INSULIN | 9 | 205 | 2.436e-07 | 7.175e-06 |
159 | NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 11 | 351 | 3.144e-07 | 9.201e-06 |
160 | BIOLOGICAL ADHESION | 18 | 1032 | 3.164e-07 | 9.201e-06 |
161 | REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 17 | 926 | 3.488e-07 | 1.008e-05 |
162 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 14 | 616 | 3.51e-07 | 1.008e-05 |
163 | REGULATION OF CHEMOKINE PRODUCTION | 6 | 65 | 3.571e-07 | 1.019e-05 |
164 | REGULATION OF MULTICELLULAR ORGANISM GROWTH | 6 | 66 | 3.914e-07 | 1.111e-05 |
165 | POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 10 | 289 | 4.571e-07 | 1.289e-05 |
166 | POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 5 | 37 | 5.112e-07 | 1.433e-05 |
167 | INTERFERON GAMMA MEDIATED SIGNALING PATHWAY | 6 | 70 | 5.572e-07 | 1.552e-05 |
168 | POSITIVE REGULATION OF INFLAMMATORY RESPONSE | 7 | 113 | 5.667e-07 | 1.57e-05 |
169 | REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 5 | 38 | 5.867e-07 | 1.615e-05 |
170 | NEGATIVE REGULATION OF MOLECULAR FUNCTION | 18 | 1079 | 6.063e-07 | 1.66e-05 |
171 | REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 5 | 39 | 6.707e-07 | 1.825e-05 |
172 | NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 18 | 1087 | 6.749e-07 | 1.826e-05 |
173 | GLUCOSE HOMEOSTASIS | 8 | 170 | 6.978e-07 | 1.866e-05 |
174 | CARBOHYDRATE HOMEOSTASIS | 8 | 170 | 6.978e-07 | 1.866e-05 |
175 | LEUKOCYTE CHEMOTAXIS | 7 | 117 | 7.178e-07 | 1.909e-05 |
176 | POSITIVE REGULATION OF MAPK CASCADE | 12 | 470 | 7.806e-07 | 2.064e-05 |
177 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 17 | 983 | 8.013e-07 | 2.106e-05 |
178 | NEGATIVE REGULATION OF IMMUNE RESPONSE | 7 | 121 | 9.013e-07 | 2.356e-05 |
179 | POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 4 | 18 | 9.312e-07 | 2.421e-05 |
180 | CELLULAR RESPONSE TO INTERFERON GAMMA | 7 | 122 | 9.528e-07 | 2.463e-05 |
181 | LOCOMOTION | 18 | 1114 | 9.619e-07 | 2.473e-05 |
182 | INOSITOL LIPID MEDIATED SIGNALING | 7 | 124 | 1.063e-06 | 2.719e-05 |
183 | REGULATION OF MAP KINASE ACTIVITY | 10 | 319 | 1.122e-06 | 2.854e-05 |
184 | ERBB SIGNALING PATHWAY | 6 | 79 | 1.145e-06 | 2.896e-05 |
185 | GROWTH | 11 | 410 | 1.448e-06 | 3.643e-05 |
186 | RESPONSE TO PROTOZOAN | 4 | 20 | 1.465e-06 | 3.645e-05 |
187 | RESPONSE TO LEPTIN | 4 | 20 | 1.465e-06 | 3.645e-05 |
188 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 19 | 1275 | 1.528e-06 | 3.781e-05 |
189 | REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 5 | 46 | 1.559e-06 | 3.839e-05 |
190 | REGULATION OF BODY FLUID LEVELS | 12 | 506 | 1.688e-06 | 4.134e-05 |
191 | REGULATION OF IMMUNOGLOBULIN PRODUCTION | 5 | 47 | 1.739e-06 | 4.237e-05 |
192 | REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION OF STAT PROTEIN | 4 | 21 | 1.803e-06 | 4.348e-05 |
193 | POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION OF STAT PROTEIN | 4 | 21 | 1.803e-06 | 4.348e-05 |
194 | PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 8 | 193 | 1.814e-06 | 4.351e-05 |
195 | CELLULAR RESPONSE TO INTERLEUKIN 6 | 4 | 22 | 2.197e-06 | 5.242e-05 |
196 | CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 7 | 139 | 2.288e-06 | 5.433e-05 |
197 | B CELL DIFFERENTIATION | 6 | 89 | 2.314e-06 | 5.465e-05 |
198 | PLATELET ACTIVATION | 7 | 142 | 2.639e-06 | 6.167e-05 |
199 | POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 4 | 23 | 2.651e-06 | 6.167e-05 |
200 | POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 5 | 51 | 2.628e-06 | 6.167e-05 |
201 | RESPONSE TO INTERFERON GAMMA | 7 | 144 | 2.896e-06 | 6.704e-05 |
202 | NEGATIVE REGULATION OF MAPK CASCADE | 7 | 145 | 3.033e-06 | 6.985e-05 |
203 | LIPID MODIFICATION | 8 | 210 | 3.4e-06 | 7.794e-05 |
204 | GLYCEROLIPID BIOSYNTHETIC PROCESS | 8 | 211 | 3.522e-06 | 8.034e-05 |
205 | POSITIVE REGULATION OF DEFENSE RESPONSE | 10 | 364 | 3.656e-06 | 8.297e-05 |
206 | ADAPTIVE IMMUNE RESPONSE | 9 | 288 | 4.098e-06 | 9.257e-05 |
207 | REGULATION OF DEVELOPMENTAL GROWTH | 9 | 289 | 4.215e-06 | 9.475e-05 |
208 | REGULATION OF TYPE 2 IMMUNE RESPONSE | 4 | 26 | 4.432e-06 | 9.773e-05 |
209 | REGULATION OF T HELPER CELL DIFFERENTIATION | 4 | 26 | 4.432e-06 | 9.773e-05 |
210 | RESPONSE TO INTERLEUKIN 6 | 4 | 26 | 4.432e-06 | 9.773e-05 |
211 | NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 10 | 372 | 4.431e-06 | 9.773e-05 |
212 | NEGATIVE REGULATION OF INFLAMMATORY RESPONSE | 6 | 100 | 4.57e-06 | 9.984e-05 |
213 | REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 6 | 100 | 4.57e-06 | 9.984e-05 |
214 | POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 7 | 156 | 4.922e-06 | 0.000107 |
215 | NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 6 | 102 | 5.128e-06 | 0.000111 |
216 | NEGATIVE REGULATION OF CELL ADHESION | 8 | 223 | 5.297e-06 | 0.0001141 |
217 | T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 5 | 60 | 5.927e-06 | 0.0001265 |
218 | LEUKOCYTE HOMEOSTASIS | 5 | 60 | 5.927e-06 | 0.0001265 |
219 | POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 4 | 28 | 6.03e-06 | 0.0001281 |
220 | CELL CHEMOTAXIS | 7 | 162 | 6.311e-06 | 0.0001329 |
221 | POSITIVE REGULATION OF RESPONSE TO WOUNDING | 7 | 162 | 6.311e-06 | 0.0001329 |
222 | DEFENSE RESPONSE TO VIRUS | 7 | 164 | 6.841e-06 | 0.0001434 |
223 | PHOSPHOLIPID BIOSYNTHETIC PROCESS | 8 | 235 | 7.779e-06 | 0.0001623 |
224 | REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 5 | 65 | 8.814e-06 | 0.0001831 |
225 | RESPONSE TO INTERLEUKIN 4 | 4 | 31 | 9.175e-06 | 0.0001889 |
226 | POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 4 | 31 | 9.175e-06 | 0.0001889 |
227 | POSITIVE REGULATION OF GENE EXPRESSION | 21 | 1733 | 1.022e-05 | 0.0002094 |
228 | DEFENSE RESPONSE TO OTHER ORGANISM | 11 | 505 | 1.057e-05 | 0.0002158 |
229 | REGULATION OF ALPHA BETA T CELL ACTIVATION | 5 | 68 | 1.101e-05 | 0.0002218 |
230 | RESPONSE TO TYPE I INTERFERON | 5 | 68 | 1.101e-05 | 0.0002218 |
231 | ORGAN GROWTH | 5 | 68 | 1.101e-05 | 0.0002218 |
232 | NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 14 | 829 | 1.121e-05 | 0.0002248 |
233 | MAMMARY GLAND DEVELOPMENT | 6 | 117 | 1.131e-05 | 0.0002259 |
234 | POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT1 PROTEIN | 3 | 11 | 1.235e-05 | 0.0002426 |
235 | OXALOACETATE METABOLIC PROCESS | 3 | 11 | 1.235e-05 | 0.0002426 |
236 | CREATINE METABOLIC PROCESS | 3 | 11 | 1.235e-05 | 0.0002426 |
237 | REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 3 | 11 | 1.235e-05 | 0.0002426 |
238 | INNATE IMMUNE RESPONSE | 12 | 619 | 1.313e-05 | 0.0002567 |
239 | REGULATION OF B CELL ACTIVATION | 6 | 121 | 1.371e-05 | 0.000267 |
240 | REGULATION OF MYELOID CELL DIFFERENTIATION | 7 | 183 | 1.399e-05 | 0.0002712 |
241 | REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 6 | 122 | 1.437e-05 | 0.0002775 |
242 | POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 5 | 73 | 1.56e-05 | 3e-04 |
243 | RESPONSE TO BACTERIUM | 11 | 528 | 1.601e-05 | 0.0003065 |
244 | NATURAL KILLER CELL DIFFERENTIATION | 3 | 12 | 1.642e-05 | 0.0003119 |
245 | POSITIVE REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS | 3 | 12 | 1.642e-05 | 0.0003119 |
246 | REGULATION OF ACUTE INFLAMMATORY RESPONSE | 5 | 74 | 1.668e-05 | 0.0003141 |
247 | NEGATIVE REGULATION OF HORMONE SECRETION | 5 | 74 | 1.668e-05 | 0.0003141 |
248 | POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 4 | 36 | 1.69e-05 | 0.000317 |
249 | POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 6 | 129 | 1.975e-05 | 0.000369 |
250 | B CELL PROLIFERATION | 4 | 38 | 2.104e-05 | 0.0003915 |
251 | POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION | 3 | 13 | 2.128e-05 | 0.000393 |
252 | ENERGY HOMEOSTASIS | 3 | 13 | 2.128e-05 | 0.000393 |
253 | INSULIN RECEPTOR SIGNALING PATHWAY | 5 | 80 | 2.439e-05 | 0.0004485 |
254 | POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING | 5 | 81 | 2.591e-05 | 0.0004746 |
255 | CELLULAR RESPONSE TO LIPID | 10 | 457 | 2.64e-05 | 0.0004818 |
256 | LACTATION | 4 | 41 | 2.858e-05 | 0.0005195 |
257 | NEGATIVE REGULATION OF CELL CELL ADHESION | 6 | 138 | 2.892e-05 | 0.0005237 |
258 | POSITIVE REGULATION OF SECRETION | 9 | 370 | 3.021e-05 | 0.0005449 |
259 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 10 | 465 | 3.06e-05 | 0.0005497 |
260 | POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 5 | 85 | 3.272e-05 | 0.0005856 |
261 | NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 3 | 15 | 3.365e-05 | 0.0005976 |
262 | T CELL LINEAGE COMMITMENT | 3 | 15 | 3.365e-05 | 0.0005976 |
263 | MYELOID LEUKOCYTE MEDIATED IMMUNITY | 4 | 43 | 3.46e-05 | 0.0006057 |
264 | POSITIVE REGULATION OF B CELL ACTIVATION | 5 | 86 | 3.462e-05 | 0.0006057 |
265 | REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY | 4 | 43 | 3.46e-05 | 0.0006057 |
266 | ACUTE PHASE RESPONSE | 4 | 43 | 3.46e-05 | 0.0006057 |
267 | NEGATIVE REGULATION OF DEFENSE RESPONSE | 6 | 144 | 3.675e-05 | 0.0006381 |
268 | RESPONSE TO GROWTH FACTOR | 10 | 475 | 3.663e-05 | 0.0006381 |
269 | POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 8 | 296 | 4.089e-05 | 0.0007062 |
270 | NEGATIVE REGULATION OF CHEMOKINE PRODUCTION | 3 | 16 | 4.128e-05 | 0.0007062 |
271 | CELLULAR RESPONSE TO LEPTIN STIMULUS | 3 | 16 | 4.128e-05 | 0.0007062 |
272 | REGULATION OF TYROSINE PHOSPHORYLATION OF STAT1 PROTEIN | 3 | 16 | 4.128e-05 | 0.0007062 |
273 | GLYCEROPHOSPHOLIPID METABOLIC PROCESS | 8 | 297 | 4.188e-05 | 0.0007137 |
274 | REGULATION OF HYDROLASE ACTIVITY | 17 | 1327 | 4.237e-05 | 0.0007196 |
275 | REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 7 | 218 | 4.3e-05 | 0.0007276 |
276 | REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 7 | 220 | 4.557e-05 | 0.0007682 |
277 | RESPONSE TO ANTIBIOTIC | 4 | 47 | 4.936e-05 | 0.0008291 |
278 | REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS | 3 | 17 | 4.997e-05 | 0.0008305 |
279 | REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 6 | 152 | 4.974e-05 | 0.0008305 |
280 | REGULATION OF CELL CYCLE | 14 | 949 | 4.985e-05 | 0.0008305 |
281 | GLAND DEVELOPMENT | 9 | 395 | 5.02e-05 | 0.0008312 |
282 | POSITIVE REGULATION OF CELL DEATH | 11 | 605 | 5.548e-05 | 0.0009155 |
283 | NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 6 | 156 | 5.749e-05 | 0.0009419 |
284 | NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 6 | 156 | 5.749e-05 | 0.0009419 |
285 | HEMOSTASIS | 8 | 311 | 5.791e-05 | 0.0009455 |
286 | POSITIVE REGULATION OF CHEMOKINE PRODUCTION | 4 | 49 | 5.825e-05 | 0.0009477 |
287 | SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION | 9 | 404 | 5.971e-05 | 0.0009681 |
288 | HORMONE MEDIATED SIGNALING PATHWAY | 6 | 158 | 6.171e-05 | 0.000997 |
289 | REGULATION OF SYSTEM PROCESS | 10 | 507 | 6.327e-05 | 0.001019 |
290 | REPRODUCTIVE SYSTEM DEVELOPMENT | 9 | 408 | 6.44e-05 | 0.001033 |
291 | LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 5 | 98 | 6.484e-05 | 0.001037 |
292 | EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 5 | 99 | 6.806e-05 | 0.001085 |
293 | RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 8 | 321 | 7.226e-05 | 0.001148 |
294 | NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE | 4 | 52 | 7.37e-05 | 0.001166 |
295 | REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 5 | 101 | 7.487e-05 | 0.001181 |
296 | IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 8 | 323 | 7.546e-05 | 0.001186 |
297 | NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 5 | 102 | 7.847e-05 | 0.001229 |
298 | MAMMARY GLAND EPITHELIUM DEVELOPMENT | 4 | 53 | 7.946e-05 | 0.001232 |
299 | REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS | 4 | 53 | 7.946e-05 | 0.001232 |
300 | REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY | 4 | 53 | 7.946e-05 | 0.001232 |
301 | MEGAKARYOCYTE DIFFERENTIATION | 3 | 20 | 8.3e-05 | 0.001279 |
302 | X2 OXOGLUTARATE METABOLIC PROCESS | 3 | 20 | 8.3e-05 | 0.001279 |
303 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 6 | 167 | 8.387e-05 | 0.001288 |
304 | ALPHA BETA T CELL ACTIVATION | 4 | 54 | 8.553e-05 | 0.001309 |
305 | POSITIVE REGULATION OF PROTEIN IMPORT | 5 | 104 | 8.606e-05 | 0.001309 |
306 | REGULATION OF INTERLEUKIN 6 PRODUCTION | 5 | 104 | 8.606e-05 | 0.001309 |
307 | CHEMICAL HOMEOSTASIS | 13 | 874 | 8.786e-05 | 0.001332 |
308 | CELL DEATH | 14 | 1001 | 8.832e-05 | 0.001334 |
309 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 14 | 1004 | 9.118e-05 | 0.001371 |
310 | POSITIVE REGULATION OF CELL CYCLE | 8 | 332 | 9.134e-05 | 0.001371 |
311 | NEGATIVE REGULATION OF NEURON DEATH | 6 | 171 | 9.557e-05 | 0.00143 |
312 | REGULATION OF PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION | 3 | 21 | 9.654e-05 | 0.00144 |
313 | REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 3 | 22 | 0.0001114 | 0.001657 |
314 | REGULATION OF DNA RECOMBINATION | 4 | 58 | 0.0001133 | 0.001675 |
315 | LIPID METABOLIC PROCESS | 15 | 1158 | 0.0001134 | 0.001675 |
316 | LEUKOCYTE APOPTOTIC PROCESS | 3 | 23 | 0.0001277 | 0.001863 |
317 | REGULATION OF METANEPHROS DEVELOPMENT | 3 | 23 | 0.0001277 | 0.001863 |
318 | BRANCHED CHAIN AMINO ACID METABOLIC PROCESS | 3 | 23 | 0.0001277 | 0.001863 |
319 | REGULATION OF CELLULAR PROTEIN LOCALIZATION | 10 | 552 | 0.0001275 | 0.001863 |
320 | REGULATION OF GLUCOSE IMPORT | 4 | 60 | 0.0001293 | 0.001875 |
321 | POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 4 | 60 | 0.0001293 | 0.001875 |
322 | RESPONSE TO KETONE | 6 | 182 | 0.0001345 | 0.001944 |
323 | REGULATION OF HORMONE SECRETION | 7 | 262 | 0.000136 | 0.001954 |
324 | CELLULAR LIPID METABOLIC PROCESS | 13 | 913 | 0.0001359 | 0.001954 |
325 | REGULATION OF PROTEIN IMPORT | 6 | 183 | 0.0001386 | 0.001978 |
326 | CELLULAR RESPONSE TO ALCOHOL | 5 | 115 | 0.0001384 | 0.001978 |
327 | REGULATION OF ISOTYPE SWITCHING | 3 | 24 | 0.0001455 | 0.002071 |
328 | GLYCEROLIPID METABOLIC PROCESS | 8 | 356 | 0.0001477 | 0.002096 |
329 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 12 | 801 | 0.0001576 | 0.002228 |
330 | CELLULAR EXTRAVASATION | 3 | 25 | 0.0001649 | 0.002325 |
331 | POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 4 | 64 | 0.0001663 | 0.002338 |
332 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 19 | 1784 | 0.0001683 | 0.002358 |
333 | CYTOKINE PRODUCTION | 5 | 120 | 0.000169 | 0.002361 |
334 | TAXIS | 9 | 464 | 0.0001705 | 0.002375 |
335 | PHOSPHOLIPID METABOLIC PROCESS | 8 | 364 | 0.000172 | 0.002388 |
336 | POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 5 | 121 | 0.0001757 | 0.002426 |
337 | REGULATION OF PROTEIN KINASE B SIGNALING | 5 | 121 | 0.0001757 | 0.002426 |
338 | NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 7 | 274 | 0.0001792 | 0.002467 |
339 | CELLULAR RESPONSE TO INTERLEUKIN 4 | 3 | 26 | 0.0001858 | 0.002543 |
340 | CELLULAR RESPONSE TO VITAMIN | 3 | 26 | 0.0001858 | 0.002543 |
341 | CELLULAR RESPONSE TO UV | 4 | 66 | 0.0001874 | 0.002553 |
342 | WOUND HEALING | 9 | 470 | 0.0001876 | 0.002553 |
343 | EPITHELIUM DEVELOPMENT | 13 | 945 | 0.0001908 | 0.002588 |
344 | ACTIVATION OF PROTEIN KINASE ACTIVITY | 7 | 279 | 0.0002002 | 0.002708 |
345 | REGULATION OF NATURAL KILLER CELL ACTIVATION | 3 | 27 | 0.0002084 | 0.00281 |
346 | RESPONSE TO UV | 5 | 126 | 0.0002123 | 0.002854 |
347 | REGULATION OF LIPID METABOLIC PROCESS | 7 | 282 | 0.0002137 | 0.002866 |
348 | TISSUE DEVELOPMENT | 17 | 1518 | 0.0002194 | 0.002934 |
349 | POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 4 | 69 | 0.0002226 | 0.002968 |
350 | NEGATIVE REGULATION OF SECRETION | 6 | 200 | 0.0002245 | 0.002984 |
351 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 7 | 285 | 0.000228 | 0.003019 |
352 | NEGATIVE REGULATION OF HEMOPOIESIS | 5 | 128 | 0.0002284 | 0.003019 |
353 | POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 3 | 28 | 0.0002327 | 0.003067 |
354 | NUCLEAR IMPORT | 5 | 129 | 0.0002368 | 0.003113 |
355 | NEGATIVE REGULATION OF CATABOLIC PROCESS | 6 | 203 | 0.0002432 | 0.003188 |
356 | BODY FLUID SECRETION | 4 | 71 | 0.0002486 | 0.003249 |
357 | DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 10 | 602 | 0.0002568 | 0.003346 |
358 | T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 3 | 29 | 0.0002587 | 0.003362 |
359 | ENERGY RESERVE METABOLIC PROCESS | 4 | 72 | 0.0002624 | 0.0034 |
360 | REGULATION OF PROTEIN SECRETION | 8 | 389 | 0.0002696 | 0.003485 |
361 | NEGATIVE REGULATION OF MAP KINASE ACTIVITY | 4 | 73 | 0.0002767 | 0.003556 |
362 | ACUTE INFLAMMATORY RESPONSE | 4 | 73 | 0.0002767 | 0.003556 |
363 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 10 | 609 | 0.0002815 | 0.003609 |
364 | REGULATION OF CATABOLIC PROCESS | 11 | 731 | 0.0002912 | 0.003722 |
365 | POSITIVE REGULATION OF PROTEIN SECRETION | 6 | 211 | 0.0002993 | 0.003805 |
366 | NEGATIVE REGULATION OF CYTOKINE PRODUCTION | 6 | 211 | 0.0002993 | 0.003805 |
367 | RESPONSE TO ETHANOL | 5 | 136 | 0.0003025 | 0.003835 |
368 | GRANULOCYTE MIGRATION | 4 | 75 | 0.0003069 | 0.003881 |
369 | CELLULAR RESPONSE TO RADIATION | 5 | 137 | 0.0003129 | 0.003946 |
370 | NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 3 | 31 | 0.0003163 | 0.003967 |
371 | HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE | 3 | 31 | 0.0003163 | 0.003967 |
372 | REPRODUCTION | 15 | 1297 | 0.0003878 | 0.00485 |
373 | REGULATION OF PROTEIN DEACETYLATION | 3 | 34 | 0.0004172 | 0.005202 |
374 | CELLULAR RESPONSE TO INSULIN STIMULUS | 5 | 146 | 0.0004192 | 0.005202 |
375 | T CELL RECEPTOR SIGNALING PATHWAY | 5 | 146 | 0.0004192 | 0.005202 |
376 | NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION | 4 | 82 | 0.0004317 | 0.005342 |
377 | ORGAN REGENERATION | 4 | 83 | 0.0004521 | 0.00558 |
378 | FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 4 | 84 | 0.0004732 | 0.005824 |
379 | T CELL PROLIFERATION | 3 | 36 | 0.0004947 | 0.006041 |
380 | NEGATIVE REGULATION OF BLOOD CIRCULATION | 3 | 36 | 0.0004947 | 0.006041 |
381 | T CELL SELECTION | 3 | 36 | 0.0004947 | 0.006041 |
382 | LIPID BIOSYNTHETIC PROCESS | 9 | 539 | 0.0005114 | 0.006229 |
383 | POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 4 | 86 | 0.0005174 | 0.006285 |
384 | NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 3 | 37 | 0.0005366 | 0.006436 |
385 | TRICARBOXYLIC ACID METABOLIC PROCESS | 3 | 37 | 0.0005366 | 0.006436 |
386 | RESPONSE TO DRUG | 8 | 431 | 0.0005331 | 0.006436 |
387 | REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 3 | 37 | 0.0005366 | 0.006436 |
388 | NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 3 | 37 | 0.0005366 | 0.006436 |
389 | PROTEIN IMPORT | 5 | 155 | 0.0005508 | 0.006589 |
390 | DEFENSE RESPONSE TO BACTERIUM | 6 | 237 | 0.0005544 | 0.006614 |
391 | REGULATION OF ERK1 AND ERK2 CASCADE | 6 | 238 | 0.0005668 | 0.006715 |
392 | POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 5 | 156 | 0.0005672 | 0.006715 |
393 | PROTEIN LOCALIZATION TO NUCLEUS | 5 | 156 | 0.0005672 | 0.006715 |
394 | REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS | 3 | 38 | 0.0005808 | 0.006825 |
395 | REGULATION OF GLUCONEOGENESIS | 3 | 38 | 0.0005808 | 0.006825 |
396 | DEVELOPMENTAL GROWTH | 7 | 333 | 0.0005806 | 0.006825 |
397 | EPITHELIAL CELL PROLIFERATION | 4 | 89 | 0.0005891 | 0.006904 |
398 | NEGATIVE REGULATION OF CELL ACTIVATION | 5 | 158 | 0.0006009 | 0.007025 |
399 | REGULATION OF GTPASE ACTIVITY | 10 | 673 | 0.0006162 | 0.007186 |
400 | ERBB2 SIGNALING PATHWAY | 3 | 39 | 0.0006273 | 0.007225 |
401 | ASTROCYTE DIFFERENTIATION | 3 | 39 | 0.0006273 | 0.007225 |
402 | CELLULAR RESPONSE TO NUTRIENT | 3 | 39 | 0.0006273 | 0.007225 |
403 | POSITIVE REGULATION OF CELL KILLING | 3 | 39 | 0.0006273 | 0.007225 |
404 | EMBRYO IMPLANTATION | 3 | 39 | 0.0006273 | 0.007225 |
405 | CELLULAR RESPONSE TO LIGHT STIMULUS | 4 | 91 | 0.0006406 | 0.00736 |
406 | POSITIVE REGULATION OF TRANSPORT | 12 | 936 | 0.0006459 | 0.007402 |
407 | REGENERATION | 5 | 161 | 0.0006544 | 0.007481 |
408 | REGULATION OF DNA METABOLIC PROCESS | 7 | 340 | 0.0006565 | 0.007487 |
409 | REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 3 | 40 | 0.0006761 | 0.007672 |
410 | REGULATION OF ACTIVATED T CELL PROLIFERATION | 3 | 40 | 0.0006761 | 0.007672 |
411 | RESPONSE TO WOUNDING | 9 | 563 | 0.0006983 | 0.007905 |
412 | ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 8 | 450 | 0.0007068 | 0.007982 |
413 | REGULATION OF AUTOPHAGY | 6 | 249 | 0.000718 | 0.008089 |
414 | REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS | 4 | 94 | 0.0007238 | 0.008135 |
415 | REGULATION OF B CELL MEDIATED IMMUNITY | 3 | 41 | 0.0007272 | 0.008153 |
416 | REGULATION OF NEURON DEATH | 6 | 252 | 0.0007642 | 0.008547 |
417 | POSITIVE REGULATION OF GLUCOSE TRANSPORT | 3 | 42 | 0.0007807 | 0.008711 |
418 | REGULATION OF INTERFERON GAMMA PRODUCTION | 4 | 97 | 0.0008144 | 0.009044 |
419 | REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 4 | 97 | 0.0008144 | 0.009044 |
420 | REGULATION OF SECRETION | 10 | 699 | 0.0008242 | 0.009131 |
421 | REGULATION OF PEPTIDE TRANSPORT | 6 | 256 | 0.0008293 | 0.009166 |
422 | REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 3 | 43 | 0.0008366 | 0.009181 |
423 | DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM | 3 | 43 | 0.0008366 | 0.009181 |
424 | BETA CATENIN TCF COMPLEX ASSEMBLY | 3 | 43 | 0.0008366 | 0.009181 |
425 | RESPONSE TO VITAMIN | 4 | 98 | 0.0008463 | 0.009266 |
426 | REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 5 | 172 | 0.0008812 | 0.009625 |
427 | REGULATION OF GLUCOSE TRANSPORT | 4 | 100 | 0.0009128 | 0.009946 |
428 | POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION | 7 | 360 | 0.0009176 | 0.009975 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CYTOKINE RECEPTOR ACTIVITY | 26 | 89 | 7.584e-42 | 7.045e-39 |
2 | CYTOKINE RECEPTOR BINDING | 22 | 271 | 2.653e-22 | 1.232e-19 |
3 | RECEPTOR BINDING | 35 | 1476 | 6.123e-18 | 1.896e-15 |
4 | SIGNAL TRANSDUCER ACTIVITY | 36 | 1731 | 1.137e-16 | 2.112e-14 |
5 | CYTOKINE BINDING | 13 | 92 | 1.134e-16 | 2.112e-14 |
6 | KINASE REGULATOR ACTIVITY | 14 | 186 | 5.592e-14 | 8.658e-12 |
7 | CYTOKINE ACTIVITY | 13 | 219 | 9.8e-12 | 1.301e-09 |
8 | KINASE BINDING | 18 | 606 | 8.094e-11 | 8.355e-09 |
9 | SIGNALING RECEPTOR ACTIVITY | 26 | 1393 | 8.058e-11 | 8.355e-09 |
10 | KINASE INHIBITOR ACTIVITY | 9 | 89 | 1.572e-10 | 1.46e-08 |
11 | X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 7 | 43 | 6.025e-10 | 4.552e-08 |
12 | PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 8 | 70 | 6.369e-10 | 4.552e-08 |
13 | INSULIN RECEPTOR SUBSTRATE BINDING | 5 | 11 | 5.915e-10 | 4.552e-08 |
14 | MOLECULAR FUNCTION REGULATOR | 24 | 1353 | 1.459e-09 | 9.681e-08 |
15 | PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 7 | 51 | 2.106e-09 | 1.304e-07 |
16 | RECEPTOR ACTIVITY | 26 | 1649 | 3.04e-09 | 1.765e-07 |
17 | GROWTH FACTOR RECEPTOR BINDING | 9 | 129 | 4.41e-09 | 2.41e-07 |
18 | KINASE ACTIVITY | 18 | 842 | 1.481e-08 | 7.645e-07 |
19 | ENZYME BINDING | 25 | 1737 | 4.145e-08 | 2.027e-06 |
20 | HORMONE RECEPTOR BINDING | 9 | 168 | 4.439e-08 | 2.062e-06 |
21 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 18 | 992 | 1.765e-07 | 7.809e-06 |
22 | PHOSPHATIDYLINOSITOL PHOSPHATE KINASE ACTIVITY | 4 | 16 | 5.575e-07 | 2.354e-05 |
23 | GROWTH FACTOR BINDING | 7 | 123 | 1.007e-06 | 4.067e-05 |
24 | ENZYME REGULATOR ACTIVITY | 16 | 959 | 2.827e-06 | 0.0001094 |
25 | RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 8 | 228 | 6.234e-06 | 0.0002317 |
26 | PROTEIN KINASE ACTIVITY | 12 | 640 | 1.828e-05 | 0.0006532 |
27 | GLUCOCORTICOID RECEPTOR BINDING | 3 | 14 | 2.7e-05 | 0.0009291 |
28 | ENZYME INHIBITOR ACTIVITY | 9 | 378 | 3.57e-05 | 0.001184 |
29 | GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 8 | 303 | 4.822e-05 | 0.001545 |
30 | PEPTIDE HORMONE RECEPTOR BINDING | 3 | 17 | 4.997e-05 | 0.001548 |
31 | GROWTH FACTOR ACTIVITY | 6 | 160 | 6.617e-05 | 0.001983 |
32 | PHOSPHATASE BINDING | 6 | 162 | 7.089e-05 | 0.002058 |
33 | RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 4 | 53 | 7.946e-05 | 0.002237 |
34 | PROTEIN TYROSINE KINASE ACTIVITY | 6 | 176 | 0.000112 | 0.003059 |
35 | PROTEIN PHOSPHATASE BINDING | 5 | 120 | 0.000169 | 0.004486 |
36 | PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 3 | 30 | 0.0002866 | 0.007395 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX | 7 | 20 | 1.57e-12 | 9.166e-10 |
2 | RECEPTOR COMPLEX | 12 | 327 | 1.546e-08 | 4.514e-06 |
3 | EXTRACELLULAR SPACE | 22 | 1376 | 5.394e-08 | 1.05e-05 |
4 | TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 10 | 237 | 7.274e-08 | 1.062e-05 |
5 | EXTRINSIC COMPONENT OF MEMBRANE | 10 | 252 | 1.29e-07 | 1.507e-05 |
6 | PLASMA MEMBRANE RECEPTOR COMPLEX | 8 | 175 | 8.689e-07 | 8.458e-05 |
7 | MEMBRANE PROTEIN COMPLEX | 16 | 1020 | 6.205e-06 | 0.0005177 |
8 | EXTERNAL SIDE OF PLASMA MEMBRANE | 8 | 238 | 8.534e-06 | 0.000623 |
9 | SIDE OF MEMBRANE | 10 | 428 | 1.506e-05 | 0.0009772 |
10 | TRANSFERASE COMPLEX | 12 | 703 | 4.574e-05 | 0.002671 |
11 | INTRINSIC COMPONENT OF PLASMA MEMBRANE | 19 | 1649 | 5.924e-05 | 0.003145 |
12 | CELL SURFACE | 12 | 757 | 9.277e-05 | 0.004515 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa04630_Jak.STAT_signaling_pathway | 86 | 155 | 4.344e-195 | 7.819e-193 | |
2 | hsa04151_PI3K_AKT_signaling_pathway | 29 | 351 | 1.04e-29 | 9.363e-28 | |
3 | hsa04012_ErbB_signaling_pathway | 15 | 87 | 1.809e-20 | 1.085e-18 | |
4 | hsa04380_Osteoclast_differentiation | 16 | 128 | 2.001e-19 | 9.003e-18 | |
5 | hsa04660_T_cell_receptor_signaling_pathway | 14 | 108 | 2.469e-17 | 7.569e-16 | |
6 | hsa04910_Insulin_signaling_pathway | 15 | 138 | 2.523e-17 | 7.569e-16 | |
7 | hsa04062_Chemokine_signaling_pathway | 15 | 189 | 2.96e-15 | 7.613e-14 | |
8 | hsa04650_Natural_killer_cell_mediated_cytotoxicity | 13 | 136 | 2.114e-14 | 4.757e-13 | |
9 | hsa04620_Toll.like_receptor_signaling_pathway | 11 | 102 | 6.224e-13 | 1.245e-11 | |
10 | hsa04662_B_cell_receptor_signaling_pathway | 10 | 75 | 8.323e-13 | 1.498e-11 | |
11 | hsa04664_Fc_epsilon_RI_signaling_pathway | 10 | 79 | 1.427e-12 | 2.334e-11 | |
12 | hsa04510_Focal_adhesion | 13 | 200 | 3.103e-12 | 4.654e-11 | |
13 | hsa04640_Hematopoietic_cell_lineage | 10 | 88 | 4.332e-12 | 5.999e-11 | |
14 | hsa04210_Apoptosis | 10 | 89 | 4.864e-12 | 6.254e-11 | |
15 | hsa04722_Neurotrophin_signaling_pathway | 11 | 127 | 7.128e-12 | 8.554e-11 | |
16 | hsa04973_Carbohydrate_digestion_and_absorption | 8 | 44 | 1.309e-11 | 1.472e-10 | |
17 | hsa04150_mTOR_signaling_pathway | 8 | 52 | 5.405e-11 | 5.723e-10 | |
18 | hsa04960_Aldosterone.regulated_sodium_reabsorption | 7 | 42 | 5.062e-10 | 5.062e-09 | |
19 | hsa04370_VEGF_signaling_pathway | 8 | 76 | 1.246e-09 | 1.18e-08 | |
20 | hsa04914_Progesterone.mediated_oocyte_maturation | 8 | 87 | 3.716e-09 | 3.345e-08 | |
21 | hsa04666_Fc_gamma_R.mediated_phagocytosis | 8 | 95 | 7.519e-09 | 6.445e-08 | |
22 | hsa04920_Adipocytokine_signaling_pathway | 7 | 68 | 1.662e-08 | 1.36e-07 | |
23 | hsa04670_Leukocyte_transendothelial_migration | 8 | 117 | 3.908e-08 | 3.058e-07 | |
24 | hsa04070_Phosphatidylinositol_signaling_system | 7 | 78 | 4.376e-08 | 3.282e-07 | |
25 | hsa04014_Ras_signaling_pathway | 10 | 236 | 6.991e-08 | 5.034e-07 | |
26 | hsa04810_Regulation_of_actin_cytoskeleton | 9 | 214 | 3.502e-07 | 2.425e-06 | |
27 | hsa04110_Cell_cycle | 6 | 128 | 1.889e-05 | 0.000126 | |
28 | hsa04310_Wnt_signaling_pathway | 6 | 151 | 4.794e-05 | 0.0003082 | |
29 | hsa04672_Intestinal_immune_network_for_IgA_production | 4 | 49 | 5.825e-05 | 0.0003615 | |
30 | hsa00562_Inositol_phosphate_metabolism | 4 | 57 | 0.0001058 | 0.0006347 | |
31 | hsa04120_Ubiquitin_mediated_proteolysis | 5 | 139 | 0.0003345 | 0.001942 | |
32 | hsa04350_TGF.beta_signaling_pathway | 4 | 85 | 0.0004949 | 0.002784 | |
33 | hsa04144_Endocytosis | 5 | 203 | 0.001836 | 0.01001 | |
34 | hsa04115_p53_signaling_pathway | 3 | 69 | 0.003278 | 0.01735 | |
35 | hsa04390_Hippo_signaling_pathway | 4 | 154 | 0.004402 | 0.02264 | |
36 | hsa04320_Dorso.ventral_axis_formation | 2 | 25 | 0.005141 | 0.02571 | |
37 | hsa04330_Notch_signaling_pathway | 2 | 47 | 0.01743 | 0.08479 | |
38 | hsa04010_MAPK_signaling_pathway | 4 | 268 | 0.02847 | 0.1349 | |
39 | hsa04720_Long.term_potentiation | 2 | 70 | 0.03655 | 0.1687 | |
40 | hsa04622_RIG.I.like_receptor_signaling_pathway | 2 | 71 | 0.0375 | 0.1688 | |
41 | hsa04520_Adherens_junction | 2 | 73 | 0.03945 | 0.1732 | |
42 | hsa04540_Gap_junction | 2 | 90 | 0.05739 | 0.2459 | |
43 | hsa04912_GnRH_signaling_pathway | 2 | 101 | 0.07023 | 0.2873 | |
44 | hsa04916_Melanogenesis | 2 | 101 | 0.07023 | 0.2873 |
Num | lncRNA | miRNAs | miRNAs count | Gene | Sponge regulatory network | lncRNA log2FC | lncRNA pvalue | Gene log2FC | Gene pvalue | lncRNA-gene Pearson correlation |
---|---|---|---|---|---|---|---|---|---|---|
1 | EMX2OS |
hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-22-5p;hsa-miR-32-3p;hsa-miR-330-3p;hsa-miR-3614-5p;hsa-miR-421;hsa-miR-944 | 13 | PRLR | Sponge network | -6.205 | 0.00015 | -5.28 | 0.00088 | 0.479 |
2 | HAND2-AS1 |
hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-22-5p;hsa-miR-32-3p;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-3614-5p;hsa-miR-421;hsa-miR-944 | 14 | PRLR | Sponge network | -7.871 | 0 | -5.28 | 0.00088 | 0.478 |
3 | RP11-760H22.2 | hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-142-3p;hsa-miR-15b-3p;hsa-miR-20a-3p;hsa-miR-22-5p;hsa-miR-320b;hsa-miR-9-3p;hsa-miR-944 | 10 | PRLR | Sponge network | -3.418 | 0.00912 | -5.28 | 0.00088 | 0.447 |
4 | RP11-166D19.1 |
hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-27a-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-9-5p;hsa-miR-944 | 11 | LIFR | Sponge network | -4.209 | 2.0E-5 | -4.51 | 1.0E-5 | 0.442 |
5 | LINC00284 | hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-142-3p;hsa-miR-155-5p;hsa-miR-15b-3p;hsa-miR-21-3p;hsa-miR-330-5p;hsa-miR-590-3p;hsa-miR-708-5p;hsa-miR-944 | 10 | SPRY3 | Sponge network | -5.478 | 0.02716 | -0.618 | 0.35993 | 0.417 |
6 | AC005682.5 | hsa-miR-106a-5p;hsa-miR-10a-3p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-182-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-28-5p;hsa-miR-3065-3p;hsa-miR-3065-5p | 11 | CCND2 | Sponge network | -2.193 | 0.07184 | -2.811 | 0.0014 | 0.394 |
7 | FAM66C | hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-142-3p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-22-5p;hsa-miR-3614-5p | 10 | PRLR | Sponge network | -2.927 | 0.00012 | -5.28 | 0.00088 | 0.392 |
8 | MAGI2-AS3 |
hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-142-3p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-32-3p;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-3614-5p;hsa-miR-9-3p | 13 | PRLR | Sponge network | -4.563 | 0 | -5.28 | 0.00088 | 0.391 |
9 | HAND2-AS1 |
hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-27a-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-944 | 10 | LIFR | Sponge network | -7.871 | 0 | -4.51 | 1.0E-5 | 0.386 |
10 | RP11-244O19.1 | hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-3065-3p;hsa-miR-3065-5p;hsa-miR-30d-3p;hsa-miR-93-5p | 12 | CCND2 | Sponge network | -1.318 | 0.0924 | -2.811 | 0.0014 | 0.383 |
11 | DIO3OS | hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-324-3p;hsa-miR-378a-3p | 13 | CCND2 | Sponge network | -4.295 | 0.00689 | -2.811 | 0.0014 | 0.374 |
12 | RP11-166D19.1 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-224-3p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-96-5p | 18 | CCND2 | Sponge network | -4.209 | 2.0E-5 | -2.811 | 0.0014 | 0.339 |
13 | RP11-439M11.1 | hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-20b-5p;hsa-miR-324-3p | 10 | CCND2 | Sponge network | -2.662 | 0.21003 | -2.811 | 0.0014 | 0.337 |
14 | MAGI2-AS3 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-224-3p;hsa-miR-3065-5p;hsa-miR-30d-3p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-9-3p;hsa-miR-93-5p | 19 | CCND2 | Sponge network | -4.563 | 0 | -2.811 | 0.0014 | 0.315 |
15 | RP11-284N8.3 | hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-3065-5p;hsa-miR-324-3p;hsa-miR-93-5p;hsa-miR-96-5p | 10 | CCND2 | Sponge network | -0.845 | 0.52848 | -2.811 | 0.0014 | 0.313 |
16 | EMX2OS |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-1271-5p;hsa-miR-155-5p;hsa-miR-15b-3p;hsa-miR-21-3p;hsa-miR-330-3p;hsa-miR-330-5p;hsa-miR-590-3p;hsa-miR-944 | 10 | SPRY3 | Sponge network | -6.205 | 0.00015 | -0.618 | 0.35993 | 0.312 |
17 | RP11-166D19.1 |
hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-142-3p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-33a-3p;hsa-miR-3614-5p;hsa-miR-9-5p;hsa-miR-944 | 10 | PRLR | Sponge network | -4.209 | 2.0E-5 | -5.28 | 0.00088 | 0.309 |
18 | ACTA2-AS1 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-142-3p;hsa-miR-155-5p;hsa-miR-15b-3p;hsa-miR-21-3p;hsa-miR-296-5p;hsa-miR-590-3p;hsa-miR-708-5p;hsa-miR-944 | 10 | SPRY3 | Sponge network | -6.142 | 0.00223 | -0.618 | 0.35993 | 0.306 |
19 | MIR143HG |
hsa-miR-107;hsa-miR-130b-5p;hsa-miR-16-1-3p;hsa-miR-16-5p;hsa-miR-19b-3p;hsa-miR-25-3p;hsa-miR-324-5p;hsa-miR-363-3p;hsa-miR-429;hsa-miR-940 | 10 | SOCS2 | Sponge network | -6.51 | 0 | -3.753 | 1.0E-5 | 0.303 |
20 | GAS6-AS2 | hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-28-5p;hsa-miR-3065-5p;hsa-miR-324-3p;hsa-miR-429 | 14 | CCND2 | Sponge network | -1.941 | 0.0681 | -2.811 | 0.0014 | 0.301 |
21 | TRHDE-AS1 | hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-22-5p;hsa-miR-32-3p;hsa-miR-330-3p;hsa-miR-3614-5p;hsa-miR-582-5p | 10 | PRLR | Sponge network | -6.205 | 0.01165 | -5.28 | 0.00088 | 0.297 |
22 | MAGI2-AS3 |
hsa-miR-107;hsa-miR-130b-5p;hsa-miR-16-1-3p;hsa-miR-16-5p;hsa-miR-19b-3p;hsa-miR-25-3p;hsa-miR-324-5p;hsa-miR-363-3p;hsa-miR-429;hsa-miR-940 | 10 | SOCS2 | Sponge network | -4.563 | 0 | -3.753 | 1.0E-5 | 0.295 |
23 | RP11-389C8.2 | hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-224-3p;hsa-miR-3065-3p;hsa-miR-3065-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-93-5p | 17 | CCND2 | Sponge network | -3.089 | 2.0E-5 | -2.811 | 0.0014 | 0.293 |
24 | ACTA2-AS1 |
hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130a-3p;hsa-miR-142-3p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-22-5p;hsa-miR-33a-3p;hsa-miR-3614-5p;hsa-miR-944 | 13 | PRLR | Sponge network | -6.142 | 0.00223 | -5.28 | 0.00088 | 0.291 |
25 | RP11-554A11.4 | hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-15b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-20b-5p;hsa-miR-324-3p;hsa-miR-33a-3p | 10 | CCND2 | Sponge network | -5.361 | 2.0E-5 | -2.811 | 0.0014 | 0.29 |
26 | NR2F2-AS1 | hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-1271-5p;hsa-miR-142-3p;hsa-miR-155-5p;hsa-miR-15b-3p;hsa-miR-21-3p;hsa-miR-590-3p;hsa-miR-708-5p;hsa-miR-944 | 10 | SPRY3 | Sponge network | -3.785 | 0.00281 | -0.618 | 0.35993 | 0.288 |
27 | WT1-AS |
hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-22-5p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-421;hsa-miR-9-3p;hsa-miR-9-5p;hsa-miR-944 | 13 | PRLR | Sponge network | -6.875 | 2.0E-5 | -5.28 | 0.00088 | 0.286 |
28 | MIR143HG |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-224-3p;hsa-miR-3065-3p;hsa-miR-3065-5p;hsa-miR-30d-3p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-93-5p | 21 | CCND2 | Sponge network | -6.51 | 0 | -2.811 | 0.0014 | 0.285 |
29 | DNM3OS |
hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-142-3p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-320b;hsa-miR-330-3p;hsa-miR-33a-3p | 10 | PRLR | Sponge network | -3.933 | 0.00059 | -5.28 | 0.00088 | 0.279 |
30 | ADAMTS9-AS1 |
hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-27a-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-629-3p | 10 | LIFR | Sponge network | -8.573 | 0.00012 | -4.51 | 1.0E-5 | 0.275 |
31 | MIR143HG |
hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-142-3p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-3614-5p | 10 | PRLR | Sponge network | -6.51 | 0 | -5.28 | 0.00088 | 0.267 |
32 | SOCS2-AS1 | hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-93-5p | 12 | CCND2 | Sponge network | -4.167 | 1.0E-5 | -2.811 | 0.0014 | 0.258 |
33 | RP11-597D13.9 | hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-30d-3p;hsa-miR-429;hsa-miR-93-5p;hsa-miR-96-5p | 14 | CCND2 | Sponge network | -2.494 | 0.07597 | -2.811 | 0.0014 | 0.252 |
34 | DNM3OS |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-3065-3p;hsa-miR-3065-5p;hsa-miR-30d-3p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-93-5p;hsa-miR-96-5p | 19 | CCND2 | Sponge network | -3.933 | 0.00059 | -2.811 | 0.0014 | 0.25 |